Immunoassays – News and Features

This article explores how advances in automation, 3D cell models and AI are transforming high-throughput screening, driving faster and more predictive drug discovery.

Newborns of mothers exposed to higher levels of fine airborne particles during pregnancy show slower myelination at this very early stage of life.

Study reveals how lipids guide proteins inside immune cells, enabling the precise release of cytotoxic granules used to kill infected or tumor cells.

Advanced DNA sequencing technologies and a new model of stem cell research have revealed a new type of diabetes in babies.

Researchers have now come up with a new way to engineer CAR-NK cells that makes them much less likely to be rejected by the patient’s immune system.

Researchers created the first single-cell atlas of matched primary and recurrent meningiomas, revealing how tumors evolve over time. The study identified COL6A3 as a driver of recurrence, linked to immune suppression and treatment resistance.

Small cell lung cancer cells that metastasize to the brain cozy up to neurons and form working electrical connections, new research shows.

Scientists have developed a new diagnostic test that uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.

Researchers have developed a microneedle patch that can help capture cancer biomarkers in the top-most layer of skin, enabling rapid at-home testing for melanoma – the most aggressive form of skin cancer.